Benzinga | Nov 9, 2020 04:55PM EST

Adamis Pharmaceuticals Q3 Sales $4.30M Miss $6.98M Estimate

Adamis Pharmaceuticals (NASDAQ:ADMP) reported quarterly sales of $4.30 million which missed the analyst consensus estimate of $6.98 million by 38.40 percent. This is a 27.16 percent decrease over sales of $5.90 million the same period last year.